Lorazepam (injection)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Lorazepam (injection) is a general anesthetic that is FDA approved for the {{{indicationType}}} of anxiety, insomnia, due to anxiety or situational stress, premedication for anesthetic procedure, status epilepticus. Common adverse reactions include neurologic: asthenia (4.2% ), dizziness (6.9% ), sedated (15.9% ), unsteadiness present (3.4%), psychiatric: depression.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
- Alcohol withdrawal syndrome: 2 mg ORALLY every 6 hr for 4 doses, then 1 mg every 6 hr for 8 doses.
- Anxiety: initial, 2 to 3 mg/day ORALLY divided into 2 to 3 daily doses.
- Anxiety: maintenance, 2 to 6 mg/day ORALLY divided into 2 to 3 daily doses; dose may vary from 1 to 10 mg/day.
- Chemotherapy-induced nausea and vomiting; Prophylaxis: a single dose of 0.025 to 0.05 mg/kg (MAX 4 mg) IM OR IV given slowly (2 mg/min) 30 to 35 min prior to receiving chemotherapy; this dose may be supplemented with oral lorazepam 1 to 2 mg/hr as needed.
- Insomnia, due to anxiety or situational stress: 2 to 4 mg ORALLY at bedtime.
- Premedication for anesthetic procedure: 0.05 mg/kg IM (MAX 4 mg) 2 hours before procedure.
- Premedication for anesthetic procedure: 0.044 mg/kg IV OR 2 mg (whichever is less); MAX dose 0.05 mg/kg IV OR 4 mg (whichever is less) 15 to 20 minutes before the surgical procedure.
- Sedation: (intermittent) 0.02 to 0.06 mg/kg IV every 2 to 6 hours.
- Sedation: (continuous infusion) 0.01 to 0.1 mg/kg/hr IV.
- Status epilepticus: 4 mg IV given slowly at 2 mg/min, may repeat dose in 10 to 15 min if needed; IM dosing may be used, but IV dosing is preferred.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
- Anxiety
- Insomnia, due to anxiety or situational stress
- Premedication for anesthetic procedure.
- Status epilepticus.
Non–Guideline-Supported Use
- Agitation - Psychotic disorder
- Alcohol withdrawal syndrome
- Chemotherapy-induced nausea and vomiting; Prophylaxis
- Sedation
- Seizure
- Seizure, drug-induced; Prophylaxis
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Lorazepam (injection) FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information about Off-Label Guideline-Supported Use of Lorazepam in pediatric patients.
Non–Guideline-Supported Use
There is limited information about Off-Label Non–Guideline-Supported Use of Lorazepam in pediatric patients.
Contraindications
There is limited information regarding Lorazepam (injection) Contraindications in the drug label.
Warnings
There is limited information regarding Lorazepam (injection) Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Lorazepam (injection) Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Lorazepam (injection) Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Lorazepam (injection) Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Lorazepam (injection) in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Lorazepam (injection) in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Lorazepam (injection) during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Lorazepam (injection) in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Lorazepam (injection) in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Lorazepam (injection) in geriatric settings.
Gender
There is no FDA guidance on the use of Lorazepam (injection) with respect to specific gender populations.
Race
There is no FDA guidance on the use of Lorazepam (injection) with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Lorazepam (injection) in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Lorazepam (injection) in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Lorazepam (injection) in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Lorazepam (injection) in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Lorazepam (injection) Administration in the drug label.
Monitoring
There is limited information regarding Lorazepam (injection) Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Lorazepam (injection) and IV administrations.
Overdosage
There is limited information regarding Lorazepam (injection) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Lorazepam (injection) Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Lorazepam (injection) Mechanism of Action in the drug label.
Structure
There is limited information regarding Lorazepam (injection) Structure in the drug label.
Pharmacodynamics
There is limited information regarding Lorazepam (injection) Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Lorazepam (injection) Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Lorazepam (injection) Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Lorazepam (injection) Clinical Studies in the drug label.
How Supplied
There is limited information regarding Lorazepam (injection) How Supplied in the drug label.
Storage
There is limited information regarding Lorazepam (injection) Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Lorazepam (injection) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Lorazepam (injection) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Lorazepam (injection) Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Lorazepam interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Lorazepam (injection) Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Lorazepam (injection) Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
Synonyms / Brand Names:Almazine, Alzapam, Anxiedin, Aplacassee, Ativan, Bonatranquan, Delormetazepam, Emotival, Idalprem, Lorabenz, Lorax, Loraz, Lorazepam Intensol, Lorsilan, Pro Dorm, Psicopax, Punktyl, Quait, Securit, Sedatival, Sedazin, Somagerol, Tavor, Temesta, Wypax